Mucinous Breast Cancer Stage II Completed Phase 3 Trials for Doxorubicin (DB00997)

Also known as: Mucinous breast carcinoma / Mucinous carcinoma of breast

IndicationStatusPhase
DBCOND0053761 (Mucinous Breast Cancer Stage II)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02125344A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)Treatment